Navigation Links
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
Date:5/9/2013

such as: "anticipate," "intend," "plan," "expect," "believe," "should," "may," "will" and similar references to future periods.  Examples of forward-looking statements include, among others, the projected availability of Phase 2 clinical study results for NKTR-181 and the value and potential of our technology and research and development pipeline.  Forward-looking statements are neither historical facts nor assurances of future performance.  Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.  Our actual results may differ materially from those indicated in the forward-looking statements.  Therefore, you should not rely on any of these forward-looking statements.  Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, among others, (i) our drug candidates and those of our collaboration partners are in various stages of clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval for numerous reasons including safety and efficacy findings even after positive findings in previous preclinical and clinical studies; (ii) the timing of the commencement or end of clinical trials and the commercial launch of our drug candidates may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulator
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
4. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
5. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
6. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
8. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
9. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
10. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 30, 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended March 31, 2015 on Thursday, May ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its first quarter 2015 ...
(Date:4/30/2015)...  Nektar Therapeutics (Nasdaq: NKTR ) today reported ... 31, 2015. Cash and investments in ... as compared to $262.8 million at December 31, 2014. ... 31, 2015 includes a $100.0 million milestone payment received ... sale of Movantik™(naloxegol) in the U.S. "The ...
(Date:4/30/2015)... Calif. , April 30, 2015  Isis ... it has earned a $10 million milestone payment ... undisclosed target to treat a neurological disorder.  This ... four drugs in development, under Isis, and Biogen,s ... therapies to treat neurological and neuromuscular disorders.  ...
Breaking Medicine Technology:Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 4Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 5Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 7Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 8Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 9Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 10Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 11Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 12Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen 2Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen 3
... the international shoe charity announced that PromiseCare Pharmacy will ... Soles4Souls, to help provide shoes for the charity,s relief ... Japan on March 9, 2011.   "Partner ... prescriptions, medical supplies, and health and wellness information," said ...
... 2011 Thomas Huxtable and his wife, Danielle, filed suit ... seeking compensation for injuries caused by the failure of Mr. ... been recalled.  John David Hart of the Law Offices of ... representing Mr. and Mrs. Huxtable in the lawsuit filed in ...
Cached Medicine Technology:PromiseCare Pharmacy Donates to Soles4Souls® Japanese Relief Efforts 2DePuy Recalled Hip Device Lawsuit Filed in Austin, Texas 2
(Date:5/2/2015)... 02, 2015 On Tuesday April 7th, ... (ELCH) gathered to celebrate improvements in patient care. In ... Partners (RVHP), had zero acquired ventilator associated infections, zero ... infections. ELCH was also recently named a Top Performer ... at ELCH credited the teamwork of staff from all ...
(Date:5/2/2015)... success that Veatch Dental Consulting has had over the years, ... Shields to the team. With Neida and Alex on board, ... working with dentists to ensure their success. , Neida Miranda ... She was certified as dental assistant from Texas State Technical ... the importance of oral hygiene to patients, Neida was moved ...
(Date:5/1/2015)... Jusuru International has been awarded the ... of its flagship nutritional supplement, Liquid BioCell™ Life, and ... name, new logo, new packaging, new products, and new ... to identify and promote programs that serve as examples ... congratulates Jusuru International for their outstanding accomplishments and contributions ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in ... support for telemedicine. , “Such action is unprecedented ... Congress,” said Jonathan Linkous, CEO of the American Telemedicine Association ... to embrace the use of telecommunications in the delivery of ... mission to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team raised over $89,000 ... Creek Relay team has raised almost $860,000. Quail Creek ... their biggest event, January’s Dinner and Auction; an annual Putting ... Relay for Life team was established to honor a member’s ... “I was hooked when I learned how the money raised ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... , MALVERN, Pa., Aug. 18 ... Siemens Healthcare,s SOMATOM(R) Emotion CT scanner is ... and cost-effective, the SOMATOM Emotion 16 enables facilities to not only ... also undertake high-end, detailed examinations, such as high-resolution CT angiography, which ...
... tool, researcher says , TUESDAY, Aug. 18 (HealthDay News) ... early pancreatic cancer, a new study suggests. , Prion ... known about prions outside of the brain. This ... tumors to grow more aggressively, said researchers at Case ...
... Aug. 18 VirtualHealth Technologies, Inc. (OTC Bulletin Board: ... Secure eHealth, LLC, recently received a patent as well ... and apparatus of portable information agents. The ... methodology and apparatus for a "portable information agent" which ...
... MINNEAPOLIS, Aug. 18 GoldenCare USA and American Independent ... care products from United of Omaha Life Insurance Company, a Mutual ... affordable rates. , , Cash benefit policies have ... viewed as too expensive. Now, United of Omaha makes cash benefit ...
... , , ... launched a T-shirt design competition offering the chance to combine creativity with ... Cure(R). Through Oct. 26, 2009, participants can enter Passionately Pink-inspired T-shirt ... win a weekly drawing for a $100 Hanes gift card. ...
... SAN DIEGO, Aug. 18 Aethlon Medical, Inc. ... at today,s 14th Annual Southern California Investor Conference being ... The conference is hosted by California Equity Research and ... life science, technology, media, and real estate/financial organizations. ...
Cached Medicine News:Health News:Siemens Emotion CT Receives Top Rating in KLAS Report 2Health News:Siemens Emotion CT Receives Top Rating in KLAS Report 3Health News:Abnormal Protein May Signal Pancreatic Cancer 2Health News:Secure eHealth Partner Receives Patent and Notice of Patent Allowance that is Key to Enriched Data Portability in Healthcare 2Health News:Secure eHealth Partner Receives Patent and Notice of Patent Allowance that is Key to Enriched Data Portability in Healthcare 3Health News:CA$H-First(SM) LTCi Provides First-Day Cash Benefits at Affordable Rates 2Health News:Hanes(R) and Susan G. Komen for the Cure(R) Inspire Creativity for a Cause 2Health News:Hanes(R) and Susan G. Komen for the Cure(R) Inspire Creativity for a Cause 3Health News:Hanes(R) and Susan G. Komen for the Cure(R) Inspire Creativity for a Cause 4Health News:Aethlon Medical to Present at Today's Southern California Investor Conference 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: